World News - Europe
Cognis collects EFSA approvals for DHA and Vitamin E
The European Food Safety Authority (EFSA) recently published its third batch of article 13.1 health claim opinions. This included a total of 75 opinions, relating to 808 health claims. Cognis's submitted claims on DHA and vitamin E were positive, while the speciality chemicals company's health claims in relation to CLA seem not to have been evaluated yet. There were three positive opinions on health claims concerning DHA - claims relating to normal brain function, normal vision, and maintaining normal (fasting) blood concentrations of triglycérides were all upheld - and various health claims for vitamin E were also approved, relating to its ability to protect DNA, proteins and lipids against oxidative damage. While the EFSA panel rejected some health claims relating to conjugated linoleic acid (CLA), it did not give any specific opinion about the relationship between CLA and body fat reduction. Cognis' Tonalin CLA is marketed not as a weight loss ingredient, but rather as an ingredient for body fat reduction - a benefit that has been proven in numerous human studies, conducted to the strictest standards and designed using double-blind randomisation and placebo control. "This is why we will review the opinion in detail and raise our concerns with the European Commission to clarify whether our claims will be evaluated in a later batch," says Dr Arne Ptock, global product line manager Tonalin, Cognis Nutrition & Health.
Danisco uncovers mechanism behind bacterial immunity
Joint research conducted by Danisco and one of Canada's research institutions. Université Laval, has shed light on the mechanisms behind the natural bacterial immune system CRISPR/Cas. The findings, published in the scientific journal Nature, highlight the system's potential as a simple, natural way to generate more robust organisms with built-in resistance to virus attack. The research into CRISPR (clustered regularly...